Skip to content

Brain Tumor Surgery and Postoperative Delirium

Exploring the Effects of Perioperative Dexmedetomidine on the Incidence of Postoperative Delirium, Acute and Chronic Pain, and Sleep Quality in Patients Undergoing Brain Tumor Surgery

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06863064
Enrollment
140
Registered
2025-03-07
Start date
2025-03-01
Completion date
2027-12-31
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor

Keywords

brain tumor, postoperative delirium

Brief summary

1. To explore whether the combined administration of dexmedetomidine during and after surgery in patients undergoing brain tumor resection is an effective and safe modality to prevent postoperative delirium and improve sleep quality than giving it alone after surgery. 2. To explore whether intraoperative and postoperative administration of dexmedetomidine to patients undergoing brain tumor surgery can reduce postoperative acute pain and prevent chronic pain. 3. To explore whether intraoperative and postoperative administration of dexmedetomidine to patients undergoing brain tumor surgery can provide stable anesthesia depth, hemodynamics and reduce the dose of anesthetics, thereby accelerating patient recovery.

Interventions

DRUGDexmedetomidine

During the surgery, target-controlled infusion (TCI) pumps were used, employing the Dyck model for continuous infusion of propofol, with the target plasma concentration maintained at 0.2 ng/ml. Postoperatively, propofol was infused at a rate of 0.2-0.4 mcg/kg/hr according to the intensive care unit's protocol, until the patient had the endotracheal tube removed.

DRUGNormal Saline

During the surgery, equal volumes of saline were injected. After the surgery, the patient was transferred to the intensive care unit, where propofol was continuously infused at a rate of 0.2-0.4 mcg/kg/hr according to the ICU protocol, until the endotracheal tube was removed.

Sponsors

Kaohsiung Medical University Chung-Ho Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* at least 18 years old and less than 80 years old * receive brain tumor surgery with ASA II\ III.

Exclusion criteria

* under the age of 18 or over 80 * consciousness unclear * those who have not signed a consent form * those with high anesthesia risk ASA IV or higher

Design outcomes

Primary

MeasureTime frameDescription
Assessment and Documentation of DeliriumPerioperativeConfusion assessment method in intensive care unit using questionnaire(CAM-ICU), The evaluation method is yes or no, with no being the best.

Countries

Taiwan

Contacts

Primary ContactZhi-Fu Wu
aneswu@gmail.com886+75978215

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026